ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025
Endoscopic endonasal transsphenoidal surgery in children: widening the spectrum of oncological indications in the pediatric age group.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEndoscopic endonasal transsphenoidal surgery (EETS) is increasingly used in children to treat skull base lesions. The aim of this study is to present our updated institutional experience.
methodsA retrospective analysis of all pediatric patients (≤18 years old) treated via EETS for skull base pathologies at our institution, between January 2006 and December 2022, was carried out.
resultsSixty-seven children (mean age: 11.4 years) were operated on. Overall, 85 procedures were performed, including tumor residuals/recurrences after a previous craniotomy approach (11). Considering the planned goal of surgery, GTR was achieved in 73% of the cases, while STR and PR in 100% of the cases. Pituitary adenoma was the most common histotype (20), followed by craniopharyngioma (19), chordoma and sarcoma (8), optic pathway/hypothalamic glioma (5), Rathke cleft cyst (4), germ cell tumor (3), fibrous dysplasia (3), and angiofibroma (2). After surgery, most patients experienced improvement or stability of the preoperative symptoms. No surgical mortality or late nasal and facial complications were observed. Postoperative CSF leak occurred in 10 cases (11.7%). Postoperative CSF infection happened in 4 cases (6%). Six patients (12%) presented new-onset diabetes insipidus after surgery. A total of 21 patients (31.3%) had at least 1 reoperation for recurrent or progressive disease, consisting of EETS in 17 cases (68%). Eighteen patients (26.9%) with residual and/or malignant tumors received adjuvant chemotherapy and/or radiotherapy.
conclusionsEETS provides a safe and effective minimally invasive approach to treat a wide spectrum of skull base lesions in the pediatric age group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.